Previous studies on DNA-TG levels in ALL patients
Reference | Studied region | Study subjects (N) | DNA-TG (fmol/μg DNA) | RBC-TGN* | Relationship between DNA-TG and RBC-TGN | Genotypes |
---|---|---|---|---|---|---|
Warren, |
Norway | 9† | Range 95–700 | NA | NA | NA |
Jacobsen, |
Denmark | 18 | Median 377 (range 45–1,190) | Exact level NA | Correlated (R2 = 0.78) | NA |
Nielsen, |
Denmark | 50 | Standard-risk patients: median 469 (range 292–891) | Standard risk patients: median 187 (range 114–508) nmol/mmol Hgb | Positively associated using linear mixed model estimate 1.22 (95% CI, 1.17–1.28, |
|
Intermediate-risk pati ents: median 435 (range 238–774) | Intermediate risk patients: 217 (range 127–682) nmol/mmol Hgb | |||||
High-risk patients: median 203 (range 107–389) | High-risk patients: median 267 (range 187–277) nmol/mmol Hgb | |||||
Nielsen, |
European countries | 750 | In maintenance phase 1: median 326 (IQR 229–457; range 23–1,591) | Exact level NA | Positively associated using multiple linear mixed effect model estimate 1.227 (95% CI 1.175–1.281, |
|
In maintenance phase 2: median 509 (IQR 391–666; range 44–1,559) | ||||||
Moriyama, |
Japan | 32 | Normal NUDT15 diplotypes: 9.6 ± 4.1 | NA | NA | Both |
Children with one |
||||||
One child with two |
||||||
Singapore | 32 | Normal |
NA | NA | ||
Children with one |
||||||
Children with two |
||||||
Moriyama, |
Japan | 55 | Mean 442.8 (range 78.1–1,054.0) | Mean 134.1 (range, 0.46–315.5 pmol/4 × 108 RBCs) | Correlated using Spearman rank test (R2 = 0.16, |
|
This study | South Korea | 54 | Median 106.0 (range < 10.0–407.8) | Median 238.1 (range < 10.0–672.5 pmol/8 × 108 RBCs) | Correlated using Spearman rank test (R = 0.68, |
Both |
Normal |
||||||
Children with one |
*RBC-TGN levels were differently expressed using different units in previous studies; †Ages of study subjects were not reported. Study subjects in the other studies were pediatric ALL patients. ‡Mean (±SD) DNA-TG level was expressed as fmol/μg DNA/mg mercaptopurine.
Abbreviations: ALL, acute lymphoblastic leukemia; 6-MP, mercaptopurine; CI, confidence interval; DNA-TG, DNA-incorporated 6-thioguanine; Hgb, hemoglobin; IQR, interquartile range; NA, not available; TPMT, thiopurine S-methyltransferase; RBC, red blood cell; RBC-TGN, 6-thioguanine nucleotide in erythrocytes.
© Ann Lab Med